| Association between CYP2D6* 10 genotype and survival of breast cancer patients receiving tamoxifen treatment Y Xu, Y Sun, L Yao, L Shi, Y Wu, T Ouyang, J Li, T Wang, Z Fan, T Fan, ... Annals of Oncology 19 (8), 1423-1429, 2008 | 231 | 2008 |
| p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer Y Xu, L Yao, T Ouyang, J Li, T Wang, Z Fan, B Lin, Y Lu, Y Xie Clinical Cancer Research 11 (20), 7328-7333, 2005 | 142 | 2005 |
| A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer L Zhang, Y Xu, X Jin, Z Wang, Y Wu, D Zhao, G Chen, D Li, X Wang, ... Breast cancer research and treatment 154, 423-434, 2015 | 131 | 2015 |
| Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer J Sun, Y Wang, Y Xia, Y Xu, T Ouyang, J Li, T Wang, Z Fan, T Fan, B Lin, ... PLoS genetics 11 (5), e1005228, 2015 | 119 | 2015 |
| KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing J Chen, Y Ou, Y Yang, W Li, Y Xu, Y Xie, Y Liu Nature 557 (7706), 585-589, 2018 | 117 | 2018 |
| Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer L Zhang, X Song, X Wang, Y Xie, Z Wang, Y Xu, X You, Z Liang, H Cao Breast cancer research and treatment 152, 199-208, 2015 | 104 | 2015 |
| Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy Y Xu, L Diao, Y Chen, Y Liu, C Wang, T Ouyang, J Li, T Wang, Z Fan, ... Annals of oncology 24 (6), 1498-1505, 2013 | 88 | 2013 |
| HER2 somatic mutations are associated with poor survival in HER2‐negative breast cancers T Wang, Y Xu, S Sheng, H Yuan, T Ouyang, J Li, T Wang, Z Fan, T Fan, ... Cancer science 108 (4), 671-677, 2017 | 68 | 2017 |
| Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer X Han, L Diao, Y Xu, W Xue, T Ouyang, J Li, T Wang, Z Fan, T Fan, B Lin, ... Annals of oncology 25 (6), 1158-1164, 2014 | 61 | 2014 |
| Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival Q Xu, Y Hou, P Langlais, P Erickson, J Zhu, CX Shi, M Luo, Y Zhu, Y Xu, ... BMC cancer 16, 1-16, 2016 | 51 | 2016 |
| BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer Y Chen, J Zhou, Y Xu, Z Li, X Wen, L Yao, Y Xie, D Deng Cancer science 100 (9), 1663-1667, 2009 | 36 | 2009 |
| TP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide‐based neoadjuvant chemotherapy in … Y Wang, Y Xu, J Chen, T Ouyang, J Li, T Wang, Z Fan, T Fan, B Lin, Y Xie International journal of cancer 138 (2), 489-496, 2016 | 33 | 2016 |
| A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women Y Liu, J Liao, Y Xu, W Chen, D Liu, T Ouyang, J Li, T Wang, Z Fan, T Fan, ... Human Mutation 32 (9), 1000-1003, 2011 | 33 | 2011 |
| Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer S Sheng, Y Xu, Y Guo, L Yao, L Hu, T Ouyang, J Li, T Wang, Z Fan, T Fan, ... International journal of cancer 146 (2), 487-495, 2020 | 26 | 2020 |
| Inverse correlation between Naa10p and MMP-9 expression and the combined prognostic value in breast cancer patients Y Zeng, C Liu, B Dong, Y Li, B Jiang, Y Xu, L Meng, J Wu, L Qu, C Shou Medical Oncology 30, 1-11, 2013 | 26 | 2013 |
| The association of CYP2D6* 10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women H Li, L Feng, Y Xu, L Yao, T Ouyang, J Li, T Wang, Z Fan, B Lin, J Li, Y Xie Acta Oncologica 45 (5), 597-601, 2006 | 24 | 2006 |
| BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients H Meng, L Yao, H Yuan, Y Xu, T Ouyang, J Li, T Wang, Z Fan, T Fan, B Lin, ... International Journal of Cancer 146 (11), 3044-3052, 2020 | 23 | 2020 |
| Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status Y Xu, L Yao, H Li, T Ouyang, J Li, T Wang, Z Fan, B Lin, Y Lu, O Larsson, ... Breast cancer research and treatment 97, 49-55, 2006 | 23 | 2006 |
| Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status Y Xu, L Yao, A Zhao, T Ouyang, J Li, T Wang, Z Fan, T Fan, B Lin, Y Lu, ... International journal of cancer 122 (12), 2761-2766, 2008 | 21 | 2008 |
| BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers J Sun, F Chu, J Pan, Y Zhang, L Yao, J Chen, L Hu, J Zhang, Y Xu, ... Journal of Clinical Oncology 41 (5), 991-999, 2023 | 19 | 2023 |